International Pharmaceutical Expo (INTERPHEX), a leading annual trade event dedicated to the pharmaceutical and biopharmaceutical industry, and the Parenteral Drug Association (PDA) have announced a three-year sponsorship agreement. This sponsorship aligns the objectives of both organisations to service key needs of the global pharmaceutical and biopharmaceutical industry by driving innovation and advancement.
INTERPHEX serves as a strong platform for decision-makers in the pharmaceutical and biopharmaceutical manufacturing community, bringing together over 12,000 industry professionals to learn, network and source from the latest technology, equipment, education and services. PDA is the premier global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical industry. Its mission is to develop scientifically sound, practical technical information and resources to advance science and regulation for the pharmaceutical and biopharmaceutical industry through the expertise of its more than 9,500 global members.
“Our Sponsorship of INTERPHEX reflects our support of the continued enhancement of industry learning and improvement, areas we find present at INTERPHEX,” stated Richard Johnson, President and CEO of PDA. “Non-profits and corporate entities can work together to leverage best practices in real-time, to the benefit of our industry. Our collaboration with INTERPHEX is one example of this effort and we are pleased to move forward in this shared endeavor.”
PDA will be directly involved in developing the INTERPHEX conference programming identifying speakers from industry and regulatory agencies and developing a PDA sponsored cGMP Track. PDA members will have extensive educational and networking opportunities including an exclusive Association Membership Lounge.
“A long-term Sponsorship with PDA, both on national and global levels, aligns us with thought leaders across the globe,” stated Bob Stewart, Vice President of INTERPHEX. “By fostering alliances with successful non-profit organisations like PDA, we acknowledge our investment in the future of the biopharmaceutical industry and ultimately deliver unrivaled opportunities for knowledge, interaction and professional growth.”